Cure8 news brief
Family history of CRC raises an individual’s absolute CRC risk whether or not they have IBD, and people with IBD who have multiple first‑degree relatives with CRC appear to have the largest increase in absolute risk. That could affect how often colonoscopic surveillance is recommended.
Adult patients with IBD (especially those with one or more first‑degree relatives with CRC), caregivers, gastroenterologists, and guideline developers.
New nationwide Swedish registry study compared colorectal cancer (CRC) incidence in 124,387 patients with IBD versus 1,213,641 matched comparators to assess how family history of CRC affects absolute and relative CRC risk.
Having one or more first‑degree relatives with CRC raised CRC risk similarly in patients with IBD and in comparators; the largest absolute and relative increase was among people with two or more affected first‑degree relatives. A family history of early‑onset CRC produced only a modest absolute risk increase.
The study used linked national registers (patient, cancer, death, population) and reported incidence rates and excess cases per 1,000 person‑years across family‑history subgroups.
The authors state these findings call into question current guideline emphasis on early‑onset CRC alone and suggest surveillance might prioritize those with multiple affected relatives. This brief summarizes the article abstract/summary provided by the source (Gastroenterology citation given); Cure8 did not review the full journal manuscript.
This is a registry‑based observational study from Sweden summarized by the news source and cites a Gastroenterology article. The brief is grounded in the provided article text/abstract; Cure8 did not review the full journal article. Observational registry data show associations but cannot prove causation; guideline changes would require broader review and consensus.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This study highlights factors—tumor location, age, smoking, and having IBD—that were associated with survival and progression in a Lebanese CRC cohort.
This study helps distinguish patterns of colorectal dysplasia seen in people without IBD from those seen in IBD, which may affect how pathologists and clinicians interpret biopsy findings and consider cancer risk and...
Basal crypt dysplasia is easy to miss but linked to higher risk of advanced colorectal neoplasia in longstanding IBD. Improved recognition and use of p53 immunohistochemistry or complementary biomarkers could affect...
